PDCD1 and neoplasm: The depletion of Treg cells via anti-CD25 therapy significantly increased the anti-PD-1 response in young mice [305], and Treg cell depletion in aged melanoma mouse models was ineffective in inducing antitumor immunity but completely decreased tumor growth in young mice [308].